An clinical trial of Haridra lepa for 7 days in the management of post operative wound as antiseptic

An open randamized contol clinical trial Of Haridra lepa in the management of post operative wound as antiseptic - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106227

Enrollment

Registered

2026-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T148- Other injury of unspecified body region

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Post operative patients of minor surgeries like corn excision, lipoma excision, fibro adenoma, incision and drainage, nail excision. 2 Subject with Lakshanas of Sadyovrana . 3. Wound size up to 5 centimetres 4. All linear wounds (Limbs) like CLW.

Exclusion criteria

Exclusion criteria: 1.Patient Suffering from dustavrana (Non healing wounds) 2. Patient with known history of DM, HIV, HBsAG, Tuberculosis or any other systemic. 3. Malignant ulcer. 4. Anorectal diseases. 5. Ulcer due to radiation therapy. 6. Features showing gangrene. Any complication will be excluded

Design outcomes

Primary

Measure	Time frame
Haridra lepa 1g for 7 days is effective in post operative wound managementTimepoint: 1 to 7 post operative days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Sushant Rajaram Jagdale

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Centre Ashta

sushant.jagdale27@gmail.com9561731366

Outcome results